Necrotic tissue proteins and wound bed components

Necrotic tissue proteins and wound bed components represent the non-viable, devitalized biological material—such as eschar and slough—that accumulates in chronic or acute wounds like pressure ulcers, diabetic foot ulcers, and severe burns (StatPearls, 2023). These components are primarily composed of denatured extracellular matrix (ECM) proteins, including collagen, fibrin, and elastin, which act as a physical barrier to wound contraction and epithelialization (Journal of Wound Care, 2019). Furthermore, this necrotic debris serves as a reservoir for bacterial colonization and biofilm formation, which prolongs the inflammatory phase of healing (NIH, 2021). In a therapeutic context, these proteins are the primary substrates for enzymatic debriding agents, such as collagenase clostridium histolyticum or bromelain, which utilize proteases to hydrolyze the peptide bonds of the necrotic debris (FDA, Santyl Label). By breaking down these structural remnants, the drugs facilitate the removal of the necrotic burden, thereby reducing local inflammation and allowing for the development of healthy granulation tissue. Effective targeting of these components is a critical step in wound bed preparation, transitioning the wound from a stagnant, chronic state toward active re-epithelialization and closure (PubMed, 2020).

Other names

EscharSloughDevitalized tissueWound debrisNecrotic debrisDenatured extracellular matrix

Enzymatic proteolysis and hydrolysis of denatured protein substrates within the wound bed to facilitate debridement.